PROVIDER PROFILE · NPI 1033308903
Arshia Sadreddin
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
571
Unique beneficiaries
—
Total services
9,858
Distinct HCPCS
10
Medicare payment
$133K
Peer benchmark
Total Medicare services vs. 1,670 Neurology providers in CA — top quintile (cohort median 581).
PRESCRIBING · PART D · 2024
Total Rx claims
614
Beneficiaries
—
Total drug cost
$210K
Distinct drugs
12
Brand share
72.6%
Top prescribed drugs
Carbidopa/Levodopa186 claims
Carbidopa/Levodopa144 claims
Carbidopa/Levodopa51 claims
Entacapone42 claims
Donepezil Hcl27 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$448
Payment records
10
By payment type
Food and Beverage$448
Top paying entities
Food and Beverage$448
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (5)
REFERRAL NETWORK
Where Arshia Sadreddin's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 0 inbound referrers · 7 outbound destinations.
Receives referrals from
Inbound — who sends patients here
No inbound pairs above the suppression threshold.
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| SUTTER BAY HOSPITALS | 62 | 228 |
| SUTTER BAY HOSPITALS | 44 | 157 |
| UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | 20 | 63 |
| Quest Diagnostics Nichols Institute Clinical Laboratory · San Juan Capistrano, CA | 17 | 40 |
| Laboratory Corporation Of America Clinical Laboratory · San Diego, CA | 12 | 21 |
| Jerome Barakos Diagnostic Radiology · San Francisco, CA | 12 | 25 |
| Derk Purcell Diagnostic Radiology · San Francisco, CA | 11 | 33 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE